To elucidate the mechanism of glucose lowering potency increase without additive hypoglycemia risk mediated by the combination of Cmpd1 and insulin, tissue specific IR and Akt phosphorylation levels were compared in normoglycemic and STZ-diabetic mice. The gene discussed is SOX9; the disease is Hypoglycemia.